These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 16326922
1. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. Zhao Y, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM, Nicholls DP, McDermott BJ. J Pharmacol Exp Ther; 2006 Mar; 316(3):1269-81. PubMed ID: 16326922 [Abstract] [Full Text] [Related]
2. Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components. Bell D, Zhao YY, Devine AB, McDermott BJ. Cell Physiol Biochem; 2008 Mar; 21(1-3):203-14. PubMed ID: 18209487 [Abstract] [Full Text] [Related]
3. Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency. Bell D, Zhao Y, McCoy FP, Devine AB, McDermott BJ. Cell Physiol Biochem; 2007 Mar; 20(5):269-82. PubMed ID: 17762156 [Abstract] [Full Text] [Related]
4. Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats. Bell D, Zhao YY, Kelso EJ, McHenry EM, Rush LM, Lamont VM, Nicholls DP, McDermott BJ. Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H904-14. PubMed ID: 16040721 [Abstract] [Full Text] [Related]
5. Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats. Zhou YB, Sun HJ, Chen D, Liu TY, Han Y, Wang JJ, Tang CS, Kang YM, Zhu GQ. Hypertension; 2014 Feb; 63(2):330-7. PubMed ID: 24218431 [Abstract] [Full Text] [Related]
6. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice. Pawlak JB, Wetzel-Strong SE, Dunn MK, Caron KM. Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069 [Abstract] [Full Text] [Related]
7. Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes. Bell D, Zhao Y, McCoy FP, Devine A, McDermott BJ. Cell Physiol Biochem; 2008 Feb; 21(5-6):409-20. PubMed ID: 18453748 [Abstract] [Full Text] [Related]
8. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design. Roehrkasse AM, Booe JM, Lee SM, Warner ML, Pioszak AA. J Biol Chem; 2018 Oct 12; 293(41):15840-15854. PubMed ID: 30139742 [Abstract] [Full Text] [Related]
9. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments. Thota C, Gangula PR, Dong YL, Yallampalli C. Biol Reprod; 2003 Oct 12; 69(4):1432-7. PubMed ID: 12801991 [Abstract] [Full Text] [Related]
10. Involvement of vascular endothelial growth factor signaling in CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on human vascular endothelial cells. Albertin G, Sorato E, Oselladore B, Mascarin A, Tortorella C, Guidolin D. Int J Mol Med; 2010 Aug 12; 26(2):289-94. PubMed ID: 20596610 [Abstract] [Full Text] [Related]
11. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat. Pan ChS, Jiang W, Wu ShY, Zhao J, Pang YZ, Tang ChS, Qi YF. Basic Res Cardiol; 2006 May 12; 101(3):193-203. PubMed ID: 16450076 [Abstract] [Full Text] [Related]
12. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats. Hiragushi K, Wada J, Eguchi J, Matsuoka T, Yasuhara A, Hashimoto I, Yamashita T, Hida K, Nakamura Y, Shikata K, Minamino N, Kangawa K, Makino H. Kidney Int; 2004 Feb 12; 65(2):540-50. PubMed ID: 14717924 [Abstract] [Full Text] [Related]
13. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Oliver KR, Kane SA, Salvatore CA, Mallee JJ, Kinsey AM, Koblan KS, Keyvan-Fouladi N, Heavens RP, Wainwright A, Jacobson M, Dickerson IM, Hill RG. Eur J Neurosci; 2001 Aug 12; 14(4):618-28. PubMed ID: 11556887 [Abstract] [Full Text] [Related]
14. Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension. Tadokoro K, Nishikimi T, Mori Y, Wang X, Akimoto K, Matsuoka H. Regul Pept; 2003 Apr 15; 112(1-3):71-8. PubMed ID: 12667627 [Abstract] [Full Text] [Related]
18. Angiotensin II modulates gene expression of adrenomedullin receptor components in rat cardiomyocytes. Mishima K, Kato J, Kuwasako K, Imamura T, Kitamura K, Eto T. Life Sci; 2003 Aug 15; 73(13):1629-35. PubMed ID: 12875895 [Abstract] [Full Text] [Related]
19. Adrenomedullin stimulates proliferation and inhibits apoptosis of immature rat thymocytes cultured in vitro. Belloni AS, Trejter M, Malendowicz LK, Nussdorfer GG. Peptides; 2003 Feb 15; 24(2):295-300. PubMed ID: 12668215 [Abstract] [Full Text] [Related]
20. Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3'5'-monophosphate generation in Eker rat uterine smooth muscle cell line. Thota C, Yallampalli C. Biol Reprod; 2005 Feb 15; 72(2):416-22. PubMed ID: 15469997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]